D.E. Shaw & Co
PRQR icon

D.E. Shaw & Co’s ProQR Therapeutics PRQR Stock Holding History

D.E. Shaw & Co’s Portfolio PRQR Stock Details PRQR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-110,552
Closed -$86K – 5456
2022
Q2 		$86K Buy
+110,552
New +$82.4K ﹤0.01% 4756
2022
Q1 		– Sell
-33,682
Closed -$270K – 5851
2021
Q4 		$270K Buy
+33,682
New +$256K ﹤0.01% 4728
2021
Q1 		– Sell
-12,591
Closed -$53K – 4410
2020
Q4 		$53K Sell
12,591
-5,940
-32% -$25.1K ﹤0.01% 3846
2020
Q3 		$89K Buy
18,531
+907
+5% +$4.74K ﹤0.01% 3716
2020
Q2 		$107K Sell
17,624
-7,760
-31% -$41.9K ﹤0.01% 3875
2020
Q1 		$139K Sell
25,384
-25,606
-50% -$196K ﹤0.01% 3732
2019
Q4 		$506K Buy
+50,990
New +$397K ﹤0.01% 3391
2019
Q1 		– Sell
-21,436
Closed -$338K – 3858
2018
Q4 		$338K Sell
21,436
-49,250
-70% -$904K ﹤0.01% 3291
2018
Q3 		$1.37M Buy
+70,686
New +$751K ﹤0.01% 2469
2016
Q2 		– Sell
-11,663
Closed -$57K – 3490
2016
Q1 		$57K Sell
11,663
-13,713
-54% -$69.7K ﹤0.01% 3328
2015
Q4 		$220K Sell
25,376
-5,545
-18% -$63.8K ﹤0.01% 3516
2015
Q3 		$451K Sell
30,921
-8,072
-21% -$135K ﹤0.01% 3127
2015
Q2 		$650K Buy
38,993
+23,187
+147% +$437K ﹤0.01% 3004
2015
Q1 		$346K Buy
+15,806
New +$326K ﹤0.01% 3241

Other funds holding PRQR

PFM
Privium Fund Management Amsterdam, Netherlands $480M AUM 77.45% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
MCM
M28 Capital Management Stamford, Connecticut $53.8M AUM 28.63% 1-Year Est. Return
MAM
Monaco Asset Management Monaco $542M AUM 54.4% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

D.E. Shaw & Co's PRQR Position: Q3 2022 in Review

D.E. Shaw & Co sold out of ProQR Therapeutics (PRQR) in Q3 2022, closing a stake of 110,552 shares — an estimated $86K sold.

D.E. Shaw & Co first reported a position in PRQR in Q1 2015 and held it in 14 quarters. The position peaked at $1.37M in Q3 2018. 47 funds tracked by Wall St. Rank hold PRQR as of Q3 2022.

  • D.E. Shaw & Co reported no remaining ProQR Therapeutics position as of Q3 2022 after selling out during the quarter.
  • D.E. Shaw & Co sold 110,552 ProQR Therapeutics shares in Q3 2022, an estimated $86K.
  • D.E. Shaw & Co first reported a position in ProQR Therapeutics in Q1 2015 and held it in 14 quarters.
  • D.E. Shaw & Co's ProQR Therapeutics position peaked at $1.37M in Q3 2018.
  • 47 funds tracked by Wall St. Rank held ProQR Therapeutics as of Q3 2022.

Based on D.E. Shaw & Co's 13F filing for Q3 2022, filed 14 Nov 2022.